Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy

被引：61

作者：

Jiang, Liwei ^{[1
]}

Wang, Yi-Jun ^{[1
]}

Zhao, Jing ^{[1
]}

Uehara, Mayuko ^{[1
]}

Hou, Qingming ^{[1
,5
]}

Kasinath, Vivek ^{[1
]}

Ichimura, Takaharu ^{[2
]}

Banouni, Naima ^{[1
]}

Dai, Li ^{[1
]}

Li, Xiaofei ^{[1
]}

Greiner, Dale L. ^{[3
]}

Shultz, Leonard D. ^{[4
]}

Zhang, Xiaolong ^{[6
]}

Sun, Zhen-Yu Jim ^{[7
,10
]}

Curtin, Ian ^{[10
]}

Vangos, Nicholas E. ^{[10
]}

Yeoh, Zoe C. ^{[10
]}

Geffken, Ezekiel A. ^{[10
]}

Seo, Hyuk-Soo ^{[7
,10
]}

Liu, Ze-Xian ^{[6
]}

Heffron, Gregory J. ^{[7
]}

Shah, Khalid ^{[8
,9
,11
]}

Dhe-Paganon, Sirano ^{[7
,10
]}

Abdi, Reza ^{[1
,11
]}

机构：

[1] Harvard Med Sch, Transplantat Res Ctr, Brigham & Womens Hosp, Renal Div, Boston, MA 02115 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA

[3] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA

[4] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA

[5] Qingdao Univ, Inst Neuroregenerat & Neurorehabil, Qingdao 266071, Peoples R China

[6] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China

[7] Harvard Med Sch, Blavatnik Inst, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA

[8] Harvard Med Sch, Ctr Stem Cell Therapeut & Imaging, Brigham & Womens Hosp, Boston, MA 02115 USA

[9] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA

[10] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA

[11] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA

来源：

CELL | 2020年 / 183卷 / 05期

关键词：

antitumor immune response; cancer-associated fibroblasts; granzyme B; SerpinB9;

D O I：

10.1016/j.cell.2020.10.045

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cancer therapies kill tumors either directly or indirectly by evoking immune responses and have been combined with varying levels of success. Here, we describe a paradigm to control cancer growth that is based on both direct tumor killing and the triggering of protective immunity. Genetic ablation of serine protease inhibitor SerpinB9 (Sb9) results in the death of tumor cells in a granzyme B (GrB)-dependent manner. Sb9-deficient mice exhibited protective T cell-based host immunity to tumors in association with a decline in GrB-expressing immunosuppressive cells within the tumor microenvironment (TME). Maximal protection against tumor development was observed when the tumor and host were deficient in Sb9. The therapeutic utility of Sb9 inhibition was demonstrated by the control of tumor growth, resulting in increased survival times in mice. Our studies describe a molecular target that permits a combination of tumor ablation, interference within the TME, and immunotherapy in one potential modality.

引用

页码：1219 / +

页数：33

共 59 条

[11] The Novel Role of SERPINB9 in Cytotoxic Protection of Human Mesenchymal Stem Cells
El Haddad, Najib
Moore, Robert
Heathcote, Dean
Mounayar, Marwan
Azzi, Jamil
Mfarrej, Bechara
Batal, Ibrahim
Ting, Christopher
Atkinson, Mark
Sayegh, Mohamed H.
Ashton-Rickardt, Philip G.
Abdi, Reza
[J]. JOURNAL OF IMMUNOLOGY, 2011, 187 (05) : 2252 - 2260
[12] Mesenchymal stem cells express serine protease inhibitor to evade the host immune response
El Haddad, Najib
Heathcote, Dean
Moore, Robert
Yang, Sunmi
Azzi, Jamil
Mfarrej, Bechara
Atkinson, Mark
Sayegh, Mohamed H.
Lee, Jeng-Shin
Ashton-Rickardt, Philip G.
Abdi, Reza
[J]. BLOOD, 2011, 117 (04) : 1176 - 1183
[13] Roles of the immune system in cancer: from tumor initiation to metastatic progression
Gonzalez, Hugo
Hagerling, Catharina
Werb, Zena
[J]. GENES & DEVELOPMENT, 2018, 32 (19-20) : 1267 - 1284
[14] Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
Guo, Xinyi
Zhang, Yuanyuan
Zheng, Liangtao
Zheng, Chunhong
Song, Jintao
Zhang, Qiming
Kang, Boxi
Liu, Zhouzerui
Jin, Liang
Xing, Rui
Gao, Ranran
Zhang, Lei
Dong, Minghui
Hu, Xueda
Ren, Xianwen
Kirchhoff, Dennis
Roider, Helge Gottfried
Yan, Tiansheng
Zhang, Zemin
[J]. NATURE MEDICINE, 2018, 24 (07) : 978 - +
[15] The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency
Hirst, CE
Buzza, MS
Bird, CH
Warren, HS
Cameron, PU
Zhang, ML
Ashton-Rickardt, PG
Bird, PI
[J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (02) : 805 - 815
[16] Expression of endogenous granzyme B in a subset of human primary breast carcinomas
Hu, SX
Wang, S
Wang, JP
Mills, GB
Zhou, Y
Xu, HJ
[J]. BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 135 - 139
[17] Structure of a serpin-protease complex shows inhibition by deformation
Huntington, JA
Read, RJ
Carrell, RW
[J]. NATURE, 2000, 407 (6806) : 923 - 926
[18] A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Jerby-Arnon, Livnat
Shah, Parin
Cuoco, Michael S.
Rodman, Christopher
Su, Mei-Ju
Melms, Johannes C.
Leeson, Rachel
Kanodia, Abhay
Mei, Shaolin
Lin, Jia-Ren
Wang, Shu
Rabasha, Bokang
Liu, David
Zhang, Gao
Margolais, Claire
Ashenberg, Orr
Ott, Patrick A.
Buchbinder, Elizabeth I.
Haq, Rizwan
Hodi, F. Stephen
Boland, Genevieve M.
Sullivan, Ryan J.
Frederick, Dennie T.
Miao, Benchun
Moll, Tabea
Flaherty, Keith T.
Herlyn, Meenhard
Jenkins, Russell W.
Thummalapalli, Rohit
Kowalczyk, Monika S.
Canadas, Israel
Schilling, Bastian
Cartwright, Adam N. R.
Luoma, Adrienne M.
Malu, Shruti
Hwu, Patrick
Bernatchez, Chantale
Forget, Marie-Andree
Barbie, David A.
Shalek, Alex K.
Tirosh, Itay
Sorger, Peter K.
Wucherpfennig, Kai
Van Allen, Eliezer M.
Schadendorf, Dirk
Johnson, Bruce E.
Rotem, Asaf
Rozenblatt-Rosen, Orit
Garraway, Levi A.
Yoon, Charles H.
[J]. CELL, 2018, 175 (04) : 984 - +
[19] The biology and function of fibroblasts in cancer
Kalluri, Raghu
[J]. NATURE REVIEWS CANCER, 2016, 16 (09) : 582 - 598
[20] Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth
Kar, Upendra K.
Srivastava, Minu K.
Andersson, Asa
Baratelli, Felicita
Huang, Min
Kickhoefer, Valerie A.
Dubinett, Steven M.
Rome, Leonard H.
Sharma, Sherven
[J]. PLOS ONE, 2011, 6 (05):

← 1 2 3 4 5 6 →